Back to top
more

BioNTech (BNTX)

(Real Time Quote from BATS)

$89.10 USD

89.10
233,461

+1.89 (2.17%)

Updated Apr 29, 2024 02:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for BNTX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

BioNTech SE Sponsored ADR [BNTX]

Reports for Purchase

Showing records 121 - 140 ( 152 total )

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 121

12/14/2020

Company Report

Pages: 5

FDA Grants BNT162b2 Emergency Use Authorization; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 122

12/04/2020

Company Report

Pages: 5

With BNT162b2 U.K. Approval, Focus Now Shifts to FDA; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 123

11/23/2020

Company Report

Pages: 5

BNT162b2 FDA Advisory Committee Next Month; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 124

11/10/2020

Company Report

Pages: 4

BNT162b2 Interim Data Encouraging; Key Unknowns Remain; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 125

10/20/2020

Company Report

Pages: 4

BNT162b2 Unavailable Until Post-Election; Competitor Safety Concerns; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 126

10/12/2020

Company Report

Pages: 5

BNT162b2 Submissions Initiated; Vaccine Domain Updates; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 127

09/17/2020

Company Report

Pages: 5

BioNTech to Receive Funding From German Government; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 128

09/14/2020

Company Report

Pages: 4

BNT162 Phase 3 Trial Enrollment Expansion Planned; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 129

09/11/2020

Company Report

Pages: 6

BNT162b2 Preclinical Data; Key Competitor Updates; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 25.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 130

08/21/2020

Company Report

Pages: 6

BNT162b2 Has Similar Efficacy, Better Safety vs. BNT162b1; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 25.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 131

08/12/2020

Company Report

Pages: 5

2Q20 Financial Results Reported; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 132

08/05/2020

Company Report

Pages: 4

COVID-19 Vaccine Candidate Trial Starts in China; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 133

07/31/2020

Company Report

Pages: 4

Supply Agreement Inked for Japan; FixVac Platform Advances; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 134

07/29/2020

Company Report

Pages: 4

Moderna''s COVID-19 Vaccine Pricing Likely to Get Push Back, In Our View; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 135

07/28/2020

Company Report

Pages: 4

Lead COVID-19 Vaccine Selected; Phase 2/3 Trial Initiated; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 136

07/27/2020

Company Report

Pages: 5

Upsized Equity Offering Priced; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 137

07/22/2020

Company Report

Pages: 5

United States Government Vaccine Purchase Agreement Inked; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 138

07/21/2020

Company Report

Pages: 7

BNT162b1 German Data; Rival COVID-19 Vaccines Readout; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 25.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 139

07/14/2020

Company Report

Pages: 5

BNT162b1 and BNT162b2 Receive Fast Track Designation; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party

Company: BioNTech SE Sponsored ADR

Industry: Medical - Biomedical and Genetics

Record: 140

07/02/2020

Company Report

Pages: 5

BNT162b1 Demonstrates Encouraging Early Immunogenicity; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: BURNS R

Price: 10.00

Research Provided by a Third Party